The effect on social welfare of a switch of second-generation antihistamines from prescription to over-the-counter status: A microeconomic analysis

Clinical Therapeutics

Volumn 24, Issue 4, 2002, Pages 701-716

  Shih, Ya Chen Tina ^a   Prasad, Manishi ^a   Luce, Bryan R ^a  

^a UNITED BIOSOURCE CORPORATION   (United States)

Author keywords

Consumer surplus; Deadweight loss; Patent; Rx to OTC switch; Second generation antihistamines; Social welfare

Indexed keywords

ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; DECONGESTIVE AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCORTISONE; LOPERAMIDE; NON PRESCRIPTION DRUG;

ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; DRUG CLASSIFICATION; DRUG COST; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH ECONOMICS; HEALTH INSURANCE; LAW; MEDLINE; PRESCRIPTION; SOCIAL WELFARE;

EID: 0036251199     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(02)85145-1     Document Type: Note

References (42)

1. 1-receptor antagonist drugs
2. Sedative effects of antihistamines: Safety, performance, learning, and quality of life
3. Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance
4. Changing the status of drugs from prescription to over-the-counter availability
5. Models of monopoly
6. Costs and benefits in switching from Rx to OTC
7. Switching drugs from prescription-only to over-the-counter availability: Economic benefits in the United Kingdom
8. 2-blockers
9. The costs and benefits of switching a drug from prescription-only to over-the-counter status: A review of methodological issues and current evidence
10. 2-receptor antagonists
11. 2 antagonists to over-the-counter use
12. The impact of over-the-counter availability of nasal sprays on sales, prescribing, and physician visits
13. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: The case of vaginal antifungal products
14. Rx-to-OTC switches: Promises and pitfalls
15. Why Rx manufacturers would want to make the switch to OTC
16. The effect of generic competition on prescription to over-the-counter switching
17. Persuasion or information? Promotion and the shares of brand name and generic pharmaceuticals
18. Brand loyalty, entry, and price competition in pharmaceuticals after the 1984 Drug Act
19. The market for pharmaceuticals
20. The political economy of the pharmaceutical industry
21. Toward an understanding of pharmaceutical pricing strategies through the use of simple game theoretic models
22. The demand for prescription drugs as a function of cost-sharing
23. Substitution between prescribed and over-the-counter medications
24. Advertising, concentration, and price-cost margins
25. Profit rates and market structure of advertising intensive firms
26. Allergy pills spark dispute